您的位置: 专家智库 > >

国家自然科学基金(30973702)

作品数:11 被引量:82H指数:6
相关作者:徐浩李四维尚青华史大卓陈可冀更多>>
相关机构:中日友好医院中国中医科学院西苑医院北京中医药大学更多>>
发文基金:国家自然科学基金北京市科技计划项目国家重点基础研究发展计划更多>>
相关领域:医药卫生生物学更多>>

文献类型

  • 11篇中文期刊文章

领域

  • 11篇医药卫生
  • 1篇生物学

主题

  • 4篇心病
  • 4篇冠心病
  • 3篇蛋白
  • 3篇血管
  • 2篇蛋白质
  • 2篇蛋白质组
  • 2篇蛋白质组学
  • 2篇动脉
  • 2篇心血管
  • 2篇血瘀
  • 2篇证候
  • 2篇脂蛋白
  • 2篇中医
  • 2篇中医证
  • 2篇中医证候
  • 2篇白质
  • 2篇SYNDRO...
  • 1篇胆固醇
  • 1篇蛋白酶
  • 1篇蛋白质组学研...

机构

  • 5篇中日友好医院
  • 3篇中国中医科学...
  • 2篇北京中医药大...
  • 1篇首都医科大学...
  • 1篇首都医科大学...

作者

  • 7篇徐浩
  • 2篇尚青华
  • 2篇李四维
  • 1篇文川
  • 1篇王绿娅
  • 1篇许京锋
  • 1篇刘卫红
  • 1篇周明学
  • 1篇刘洋
  • 1篇陈可冀
  • 1篇潘琳
  • 1篇史大卓
  • 1篇王欣
  • 1篇刘洋

传媒

  • 4篇Chines...
  • 2篇中国中西医结...
  • 2篇中华老年医学...
  • 2篇中西医结合心...
  • 1篇现代生物医学...

年份

  • 1篇2021
  • 1篇2016
  • 1篇2014
  • 2篇2012
  • 5篇2011
  • 1篇2010
11 条 记 录,以下是 1-10
排序方式:
中医证候演变规律研究方法的现状与展望被引量:10
2011年
证候是疾病过程中某一阶段(时点)机体对内外致病因素作出的综合反应,在疾病的发生、发展、转归过程中,证候始终处于动态变化中。疾病在不同时点、不同阶段,可表现为不同的证候,体现出一定的证候演变、转化和兼夹。
李四维刘洋徐浩
关键词:证候演变规律中医疾病过程致病因素转归过程
Evidence-based Practice Method of Integrative Chinese and Western Medicine Based on Literature Retrieval through PICO Question and Complementary and Alternative Medicine Topics被引量:1
2010年
An evidence-based practice method according to literature retrieval through PICO (Patients,Intervention,Comparison,Outcome) questions and complementary and alternative medicine (CAM) topics,which can obtain helpful evidence for guiding clinical practice,was introduced with a practical example in this paper.The knowledge of diseases and Western medicine treatment can be acquired by literature retrieval through PICO question,while searching by CAM topics may provide evidence for Chinese medicine (CM).Thus the author held that literature retrieval through both PICO question and CAM topics was an ideal evidencebased practice method for integrative Chinese and Western medicine (ICWM).However,since the standard in CM evidence hierarchy is still under study,the value of the CAM thematic retrieval method remains very limited.In the future,studies on the definition and hierarchy of CM evidences and the herb-drug interaction between Western and Chinese medicine during a combination therapy should be strengthened to improve the status of ICWM evidence-based practice.
闫秀峰倪青魏军平徐浩
黄连提取物对动脉硬化小鼠斑块胶原类型及MMP-9/TIMP-1比值的影响被引量:3
2012年
目的:探讨黄连提取物对高脂喂养ApoE-/-小鼠主动脉AS斑块内胶原类型及基质金属蛋白酶-9(MMP-9)与基质金属蛋白酶组织抑制剂(TIMP-1)比值的影响,探讨黄连提取物稳定斑块的可能作用机制。方法:33只6-8周龄的ApoE基因敲除小鼠予高脂喂养13周后,待其形成成熟的AS斑块后,随机分为3组:模型组、黄连提取物组、辛伐他汀组(阳性对照组),每组11只。继续高脂喂养,并按体重比折算给予小鼠临床推荐剂量的相应药物治疗13周,处死动物,每只小鼠取主动脉根部的4个切面,行天狼猩红染色,检测各组小鼠主动脉斑块内Ⅰ、Ⅲ型胶原含量,以及斑块内MMP-9和TIMP-1的表达,计算MMP-9/TIMP-1比值。结果:给药13周后,图像分析结果显示,黄连提取物组小鼠主动脉斑块内Ⅰ型胶原含量与模型组比较有所增加,但无显著差异(P>0.05);辛伐他汀组和黄连提取物组小鼠主动脉斑块内Ⅲ型胶原含量与模型组比较显著降低(P<0.01)。Ⅲ型/Ⅰ型胶原比值,两给药组与模型组比较均显著降低(P<0.01)。与模型组比较,黄连提取物和辛伐他汀组小鼠主动脉斑块内MMP-9的阳性表达均明显减少(P<0.01),黄连提取物组主动脉斑块内TIMP-1的阳性表达与模型组相比明显增加(P<0.01),辛伐他汀组TIMP-1表达有所增加,但无统计学差异(P>0.05),两给药组之间比较无显著差异(P>0.05)。各给药组中MMP-9/TIMP-1比值均有所降低,与模型组比较具有显著差异(P<0.05,P<0.01)。结论:在临床推荐剂量下,黄连提取物可明显改善ApoE-/-小鼠主动脉AS斑块内胶原类型,调整斑块内MMP-9/TIMP-1比值,从而促进斑块稳定。
周明学徐浩王绿娅刘卫红潘琳
关键词:黄连提取物易损斑块基质金属蛋白酶-9金属蛋白酶组织抑制剂-1
Multifactor Dimensionality Reduction Analysis of the Correlation of Chinese Medicine Syndrome Evolvement and Cardiovascular Events in Patients with Stable Coronary Heart Disease被引量:15
2014年
Objective:To analyze the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease(CHD).Methods:This prospective cohort study investigated and collected the clinical information of patients with stable CHD and observed the syndrome type at the baseline and6-month at follow-up,as well as the cardiovascular events during the 6-month and 12-month follow-up.The patients were divided into the event group and the non-event group.The interaction and the impact of syndrome evolvement on cardiovascular events were examined through multifactor dimensionality reduction(MDR)analysis and the results were verified by Chi-square test.Results:Totally 1,333 of 1,503 stable CHD patients enrolled met the inclusion criteria of MDR analysis.Among them,959(71.9%)cases were males and 374(28.1%)cases were females.Thirty seven cases had cardiovascular events during 6 to 12 months after the study began.The results of the MDR analysis and verification using Chi-square test showed that the development of cardiovascular events was positively correlated with interaction between blood stasis and toxic syndrome at the baseline,blood stasis at the baseline and qi deficiency at the 6-month follow-up,toxic syndrome at the baseline and qi deficiency at the 6-month follow-up,toxic syndrome at the base line and blood stasis at the 6-month follow-up,qi deficiency and blood stasis at the 6-month follow-up(P<0.05for all).Conclusions:Blood stasis,toxic syndrome and qi deficiency are important factors of stable CHD.There are positive correlation between cardiovascular events and syndrome evolution from blood stasis to qi deficiency,from toxic syndrome to qi deficiency and from toxic syndrome to blood stasis,indicating the pathogenesis of toxin consuming qi,toxin leading to blood-stasis in stable CHD patients prone to recurrent cardiovascular events.
焦阳李四维尚青华付长庚高铸烨徐浩史大卓陈可冀
关键词:心血管中国医药
The New Strategy for Modulating Dyslipidemia:Consideration from Updated Understanding on High-Density Lipoprotein被引量:9
2011年
与关于血类脂化合物和动脉粥样硬化的进一步的研究,特别在剩余的概念以后心血管的风险,高密度的脂蛋白胆固醇(高级数据链路控制) 对动脉粥样硬化成为一个新治疗学的目标。然而,失败照亮目标为提起高级数据链路控制的学习在整个世界铺平失望心脏病专家,它在代表 HDL 显示高级数据链路控制集中的限制功能。到质量的从数量的 HDL 的更新的理解在阻止并且对待 dyslipidemia 和动脉粥样硬化为综合的中国、西方的药带一个新有关物件之特写点。除了在直接干涉的低密度的脂蛋白胆固醇加亮 statins,我们应该在全面规定充分利用中国药的优势并且有个性治疗支持病人的 self-healing 能力,它进一步调整集中的反常和整个血类脂化合物家庭的功能到平衡。为有从西方、中国的药的优点的相互的补充的 modulating dyslipidemia 的这新策略将无疑在未来治疗起一个重要作用。
文川徐浩
以高密度脂蛋白胆固醇为治疗靶点的研究进展被引量:2
2012年
高密度脂蛋白胆固醇(HDL—C)是冠心病独立负性相关危险因素,HDL—C水平每下降0.026mmol/L,心血管疾病危险上升2%~3%,每升高0.026mmol/L,心血管病死亡危险性下降6%,
文川徐浩
关键词:高密度脂蛋白胆固醇治疗靶点相关危险因素心血管病冠心病HDL
Study on the Tongue Manifestations for the Blood-Stasis and Toxin Syndrome in the Stable Patients of Coronary Heart Disease被引量:16
2011年
Objective:To explore the tongue manifestations for the blood-stasis and toxin syndrome in the stable patients of coronary heart disease(CHD) according to the acute cardiovascular events(ACEs) in one-year follow-up which based on the pathogenesis hypothesis of 'blood-stasis and toxin causing catastrophe'.Methods: Totally 254 stable CHD cases were enrolled after diagnosed by coronary angiography,their tongue appearances were recorded by the digital camera of uniform type,29 cases with ACEs during one-year follow-up were assigned in ACEs group.The non-ACEs were matched in proportion of 2:1 according to the gender,age(±2.5 years), diabetes mellitus history and previous acute coronary syndrome hospitalization history in the non-ACEs group, and 54 cases were eligibly included.The differences of tongue appearance between the ACEs and non-ACEs group were compared.Results:Fifteen cases manifested with bluish tongue(including bluish-grounding or bluish purple tongue),among which 11 cases(37.9%) in the ACEs group and four cases(7.4%) in the non-ACEs group, and there was significant difference(P<0.002).Twenty six cases showed yellow tongue coating in the non-ACEs group,which was significantly higher than that in the ACEs group(48.1 vs.10.3%,P=0.001).The tongue of sticky greasy coating was more frequently occurred in the non-ACEs group than that in the ACEs group(66.7%vs. 41.4%,P=0.026).The proportion of purplish-red sublingual vessel was higher in the ACEs group than that in the non-ACEs group(41.4%vs.20.4%,P=0.041).Odd ratio(OR) analysis showed that the patients with bluish tongue, purplish-red sublingual vessel,dry-greasy or dirty greasy coating were more likely to experience ACEs during one-year follow-up(OR:11.67,95%CI:3.34-40.81,P<0.001;OR:2.76,95%CI:1.02-7.44,P<0.05;OR:3.12,95%, CI:0.89-10.92,P=0.066).Conclusions:The bluish tongue(including bluish-grounding or bluish purple tongue) and purplish-red sublingual vessel were potential tongue manifestations of blood-stasis and toxin.The tongue coating changing from sticky
冯妍徐浩曲丹郑峰史大卓陈可冀
关键词:血瘀ACE
冠心病及其不同亚型中医证候分布特点的研究进展被引量:10
2011年
冠心病是严重危害人类健康的常见病、多发病,包括心绞痛、急性心肌梗死(AMI)、心律失常及心功能不全等临床亚型,是导致人类死亡的第一杀手。中医药在防治冠心病方面显示一定效果和良好的前景,尤以基于辨证论治的个体化治疗为特色。证候在中医辨证论治中起着承上启下的作用,它由结合病因病机而启,
刘洋李四维徐浩
关键词:证候分布临床亚型冠心病中医辨证论治心功能不全
心脑血管疾病危险评估方法学研究进展被引量:3
2011年
心脑血管疾病是严重威胁人类健康的一类疾病,据美国心脏病、学会调查结果显示,美国冠心病、脑卒中、心力衰竭的死亡人数分别占总体死亡人数的1/5、1/8、1/8[1]。有学者预测,到2020年,全球缺血性心脏病死亡将从1990年的630万增到1100万,30年内缺血性心脏病死亡将增加74.6%比[2]。
尚青华徐浩
关键词:心脑血管疾病缺血性心脏病心力衰竭
冠心病“毒证”与传统外科“毒证”蛋白质组学差异研究被引量:1
2016年
目的通过对中医传统"毒证"和冠心病(CHD)"毒证"的组间比较,探讨冠心病"毒证"的特异蛋白表达,为冠心病"毒证"理论的生物学基础提供依据。方法选择急性心肌梗死(AMI)、传统外科"毒证"病人各15例,采用Matrix Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectroscopy(Maldi-Tof-MS)方法对两组人群血清蛋白进行比较分析和鉴定,最终确定CHD"毒证"和传统毒证的差异蛋白。结果共找到4个有明显统计学意义的蛋白多肽链,其中分子量为2 022.61Da的多肽链LOC653879(补体3类似物,Similar to Complement C3)组间差异最大,且能很好地将这两组区分;用QC方法建立的模型示该蛋白多肽链能够很好地与其他蛋白相结合,得到的识别率为93.33%。结论补体C3类似物LOC653879是区别冠心病"毒证"与传统外科"毒证"的关键蛋白,值得进一步研究。
许京锋尚青华王欣徐浩
关键词:冠心病蛋白组学
共2页<12>
聚类工具0